NPR News: 04-01-2026 2PM EDT

Summary of NPR News: 04-01-2026 2PM EDT

by tester

4m•April 1, 2026
Listen to Episode

Overview of NPR News: 04-01-2026 2PM EDT

A fast-paced roundup of major U.S. and global stories: the U.S. Supreme Court heard arguments on President Trump’s bid to limit birthright citizenship; the White House and Iran traded claims about a possible ceasefire as the conflict enters its fifth week; the FDA approved a new oral obesity drug from Eli Lilly; NASA’s Artemis 2 crew heads to the launch pad amid questions about how the agency is talking about crew diversity; and Hershey said it will return Reese’s products to their classic recipes. Reporters cited include Carrie Johnson, Deepa Shivaram, Sydney Lupkin, Katie Riddle and others.

Key stories (at-a-glance)

  • Supreme Court hears arguments on Trump executive order to end birthright citizenship; several justices appeared skeptical. Decision expected near end of term (summer).
  • President Trump to address the nation at 9 p.m. ET on the U.S.-Iran conflict; U.S. and Israel campaign against Iran enters fifth week amid disputed claims of a ceasefire request.
  • FDA approves Eli Lilly’s new oral obesity pill, Fundeo (orforglipron), a non-peptide oral GLP-style drug; pricing and insurance assistance announced.
  • NASA’s Artemis 2 (first lunar mission in 54 years) preparing for launch; crew represents historic firsts but agency pulled diversity language from website after new administration actions.
  • Hershey will revert Reese’s products to classic recipes next year after public pushback from a descendant of the product’s inventor.
  • Markets: Dow up 324 points.

Supreme Court — birthright citizenship

  • What happened: The Court heard arguments over President Trump’s day-one executive order aiming to end automatic U.S. citizenship for babies born to people in the U.S. illegally or temporarily present.
  • Key details:
    • NPR’s Carrie Johnson reports that a majority of justices — including some Trump appointees — sounded skeptical of the administration’s effort during oral arguments.
    • If upheld, the order could affect roughly 250,000 births per year and might be cited to challenge citizenship for people born earlier.
    • Opponents argued (per the transcript) that accepting the administration’s view would “radically rewrite the Constitution and upend more than 150 years of settled law.”
    • A decision is expected by the end of the Court’s term this summer.
  • Implication: A ruling for the administration would be a major constitutional and civic change with large practical consequences for parents and children born on U.S. soil.

U.S.-Iran conflict and Trump address

  • What happened: President Trump is scheduled to address the nation at 9 p.m. ET about the ongoing military campaign against Iran; thousands of U.S. troops are in the region.
  • Key details:
    • Trump claimed Iran’s new leader asked the U.S. for a ceasefire and said he’d consider one only if the Strait of Hormuz were opened; otherwise, attacks would continue.
    • Iran’s foreign ministry rejected Trump’s claim as “false and baseless.”
    • Trump said the war should end in the next two to three weeks.
  • Implication: The situation remains volatile and contested; the president’s address could clarify U.S. goals and near-term military plans.

FDA approves Eli Lilly’s new oral obesity drug

  • What happened: The FDA approved Fundeo, an Eli Lilly oral obesity medicine whose active compound is orforglipron (a non-peptide oral GLP-style agent), not a pill version of ZepBound’s ingredient.
  • Key details:
    • Daniel Skowronski (Lilly’s chief scientific and medical officer) explained the drug differs from previously peptide-based GLP medicines that required injections or special pill formulations.
    • Pricing: Lilly hasn’t announced a full list price. Company says commercially insured patients could pay as little as $25/month via coverage programs; lowest cash price quoted was $149/month for the smallest dose.
  • Implication: Adds an orally dosed option to obesity treatments, potentially expanding access, but real-world affordability will depend on insurance coverage and final pricing.

Artemis 2 lunar mission and NASA messaging on diversity

  • What happened: Artemis 2 astronauts are moving to the launch pad for the first crewed lunar mission in 54 years; the crew includes historic firsts (first Black man and first woman on such a mission).
  • Key details:
    • Early NASA communications highlighted these diversity milestones; since the new administration’s executive actions limiting DEI language, NASA has removed celebratory language from its site.
    • Advocates say explicitly recognizing inclusion matters for representation and outreach in the space field.
    • NASA plans further lunar missions, possibly returning to the moon’s surface.
  • Implication: The mission is historically significant both technically and symbolically; changes to official messaging have raised concerns among diversity advocates.

Hershey reverses recipe changes for Reese’s

  • What happened: After a public letter from Brad Reese (grandson of Reese’s inventor) criticizing ingredient changes, Hershey said it will return Reese’s products to classic recipes starting next year.
  • Implication: A consumer-driven reversal that could affect production/processes and ingredient sourcing; highlights brand sensitivity to legacy recipes and public backlash.

Notable quotes

  • “Agreeing with the president would radically rewrite the Constitution and upend more than 150 years of settled law.” — argument made by challengers to the birthright-citizenship order (as reported).
  • Iran’s foreign ministry called Trump’s assertion that Iran asked for a ceasefire “false and baseless.”
  • Daniel Skowronski (Lilly): former GLP drugs “have been peptides, meaning they need to be taken as injections or as a pill with restrictions,” explaining why an oral, non-peptide approach matters.
  • AJ Link (Black and Astro): called explicit acknowledgment of crew diversity “really important” and said erasing that is wrong.

Bottom-line takeaways

  • The Supreme Court’s decision on birthright citizenship could produce sweeping legal and social changes; watch for a ruling this summer.
  • The conflict with Iran remains active and contested; expect further announcements from the White House after tonight’s address.
  • Fundeo (orforglipron) offers an oral alternative in obesity treatment—pricing and insurance coverage will determine patient access.
  • Artemis 2 is a major milestone for NASA and representation in spaceflight; debates over agency communications reflect larger tensions over federal DEI policies.
  • Hershey’s reversal on Reese’s recipes shows the power of public/provenance sentiment on corporate decisions.

Suggested follow-ups / where to look next

  • Read the Supreme Court’s published order or opinion when released (expected end of term).
  • Watch President Trump’s 9 p.m. ET address and subsequent White House readouts for policy specifics on Iran.
  • Check the FDA approvals page and Eli Lilly’s patient-cost/insurance guidance for prescription details and eligibility.
  • Monitor NASA announcements for Artemis 2 launch timing and mission updates.
  • Hershey corporate communications for exact timelines and product details on recipe changes.